ArticleOphthalmology science2026
Evaluation of Hyaloid Artery Persistence as a Biomarker in Retinopathy of Prematurity Using OCT.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Objective: To evaluate whether hyaloid artery persistence, detected by handheld OCT, is associated with retinopathy of prematurity (ROP) severity. Design: A retrospective cohort study. Subjects: A total of 162 eyes of preterm infants undergoing ROP screening at a tertiary care neonatal intensive care unit were included. Methods: Handheld ultra-widefield OCT images were reviewed at each clinical encounter for the presence or absence of the hyaloid artery. Time to hyaloid artery disappearance was modeled using a Weibull accelerated failure time survival analysis incorporating interval censoring and clustering within subjects. Covariates included ROP severity (mild, moderate, or severe) and gestational age (GA). Leave-one-eye-out cross-validated area under the receiver operating characteristic curves (AUROCs) were calculated to evaluate the discriminative ability of hyaloid regression timing for ROP severity. Main Outcome Measures: The primary outcomes were postnatal age (PNA) at hyaloid artery disappearance and AUROC values for No vs. Mild, No vs. Severe, and Mild vs. Severe ROP. Results: The hyaloid artery was detectable by OCT in 152 of 162 (94%) eyes. Compared with eyes with No ROP, hyaloid artery persistence was significantly prolonged in Mild ROP (acceleration factor [AF], 1.354; Conclusions: The hyaloid artery is commonly detectable in preterm infants using OCT. Persistence of the hyaloid artery is significantly associated with increasing ROP severity and may serve as a novel, quantifiable biomarker of disease severity and retinal maturation. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.